Vitamin D: Emerging new roles in insulin sensitivity

Nutrition Research Reviews

Volumn 22, Issue 1, 2009, Pages 82-92

  Teegarden, Dorothy ^a   Donkin, Shawn S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Diabetes; Insulin resistance; Insulin sensitivity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; GLUCOSE; INSULIN; INSULIN RECEPTOR; PARATHYROID HORMONE; VITAMIN D;

BODY COMPOSITION; CLINICAL TRIAL; DRUG MECHANISM; GENOTYPE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEMIPLEGIA; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN EXPRESSION; REVIEW; UREMIA; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; DIET SUPPLEMENTATION; GENETIC POLYMORPHISM; GENETICS; GLUCOSE BLOOD LEVEL; INCIDENCE; INFLAMMATION; METABOLISM; PHYSIOLOGY; UNITED STATES;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; INCIDENCE; INFLAMMATION; INSULIN; INSULIN RESISTANCE; PARATHYROID HORMONE; POLYMORPHISM, GENETIC; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 69249215473     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422409389301     Document Type: Review

References (110)

1. World Health Organization (2006) Fact Sheet no. 312. Diabetes. http://www.who.int/mediacentre/factsheets/fs312/en
2. Boucher BJ (1998) Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'? Br J Nutr 79, 315-327.
3. Teegarden D (2006) Dietary calcium and the metabolic syndrome. In Calcium and Human Health, pp. 401-409 [C Weaver and R Heaney, editors]. Totowa, NJ: Humana Press Inc.
4. Mathieu C, Gysemans C, Giulietti A, et al. (2005) Vitamin D and diabetes. Diabetologia 48, 1247-1257.
5. 3 as modulators in the immune system. J Steroid Biochem Mol Biol 89-90, 449-452.
6. 2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 200, 295-302.
7. 3 and parathyroid hormone. J Cell Biochem 88, 234-237.
8. Heaney RP (2003) Sensitivity of parathyroid hormone response to calcium intake. Am J Clin Nutr 78, 493-495.
9. Harkness L & Cromer B (2005) Low levels of 25-hydroxy vitamin D are associated with elevated parathyroid hormone in healthy adolescent females. Osteoporosis Int 16, 109-113. (Pubitemid 40193226)
10. Krall EA, Sahyoun N, Tannenbaum S, et al. (1989) Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 321, 1777-1783. (Pubitemid 20015570)
11. Weaver CM & Fleet JC (2004) Vitamin D requirements: current and future. Am J Clin Nutr 80, 1735S-1739S.
12. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. (2002) Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 76, 187-192. (Pubitemid 34686565)
13. Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80, 1678S-1688S.
14. Heaney RP & Weaver CM (2003) Calcium and vitamin D. Endocrinol Metab Clin North Am 32, 181-194, vii-viii.
15. Procopio M & Borretta G (2003) Derangement of glucose metabolism in hyperparathyroidism. J Endocrinol Invest 26, 1136-1142.
16. Pittas AG, Lau J, Hu FB, et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017-2029. (Pubitemid 46997093)
17. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, et al. (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10, 185-197. (Pubitemid 351249776)
18. Choi HK, Willett WC, Stampfer MJ, et al. (2005) Dairy consumption and risk of type 2 diabetes mellitus in men - a prospective study. Arch Intern Med 165, 997-1003. (Pubitemid 40638119)
19. Parikh SJ & Yanovski JA (2003) Calcium intake and adiposity. Am J Clin Nutr 77, 281-287.
20. Teegarden D (2005) The influence of dairy product consumption on body composition. J Nutr 135, 2749-2752. (Pubitemid 43156536)
21. Lin YC, Lyle RM, McCabe LD, et al. (2000) Dairy calcium is related to changes in body composition during a two-year exercise intervention in young women. J Am Coll Nutr 19, 754-760.
22. Zemel MB, Shi H, Greer B, et al. (2000) Regulation of adiposity by dietary calcium. FASEB J 14, 1132-1138.
23. Barr SI (2003) Increased dairy product or calcium intake: is body weight or composition affected in humans? J Nutr 133, 245S-248S.
24. Shapses SA, Heshka S & Heymsfield SB (2004) Effect of calcium supplementation on weight and fat loss in women. J Clin Endocrinol Metab 89, 632-637. (Pubitemid 38269870)
25. Gunther CW, Legowski PA, Lyle RM, et al. (2005) Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention. Am J Clin Nutr 81, 751-756.
26. Teegarden D, White KM, Lyle RM, et al. (2008) Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 16, 1566-1572. (Pubitemid 351915103)
27. 3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 7, 4.
28. Pfeifer M, Begerow B & Minne HW (2002) Vitamin D and muscle function. Osteoporos Int 13, 187-194.
29. Boland R (1986) Role of vitamin D in skeletal muscle function. Endocr Rev 7, 434-448.
30. Visser M, Deeg DJ & Lips P (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88, 5766-5772. (Pubitemid 38033048)
31. Bischoff HA, Stahelin HB, Urscheler N, et al. (1999) Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 80, 54-58. (Pubitemid 29035822)
32. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged . or > 60 y. Am J Clin Nutr 80, 752-758. (Pubitemid 41115542)
33. Pfeifer M, Begerow B, Minne HW, et al. (2001) Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 109, 87-92. (Pubitemid 32294575)
34. Mowe M, Haug E & Bohmer T (1999) Low serum calcidiol concentration in older adults with reduced muscular function. J Am Geriatr Soc 47, 220-226. (Pubitemid 29082723)
35. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291, 1999-2006.
36. Arabi A, Baddoura R, Awada H, et al. (2006) Hypovitaminosis D osteopathy: is it mediated through PTH, lean mass, or is it a direct effect? Bone 39, 268-275.
37. Sato Y, Iwamoto J, Kanoko T, et al. (2005) Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 20, 187-192. (Pubitemid 41254180)
38. Siddiqui S, Chang E, Zou M, et al. (2007) High dietary calcium and vitamin D effects on fat mass accretion and expression of liver enzymes in rats. FASEB J 21, A56.
39. Endo I, Inoue D, Mitsui T, et al. (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144, 5138-5144. (Pubitemid 37476038)
40. Liu S, Song Y, Ford ES, et al. (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28, 2926-2932. (Pubitemid 43942926)
41. Pittas AG, Dawson-Hughes B, Li T, et al. (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650-656. (Pubitemid 44115368)
42. Scragg R, Sowers M & Bell C (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27, 2813-2818. (Pubitemid 39565042)
43. Martins D, Wolf M, Pan D, et al. (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167, 1159-1165. (Pubitemid 46919818)
44. Reis JP, von Mühlen D, Kritz-Silverstein D, et al. (2007) Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30, 1549-1555. (Pubitemid 46871169)
45. Ford ES, Ajani UA, McGuire LC, et al. (2005) Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 28, 1228-1230. (Pubitemid 40616645)
46. Baynes KCR, Boucher BJ, Feskens EJM, et al. (1997) Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40, 344-347. (Pubitemid 27096561)
47. Need AG, O'Loughlin PD, Horowitz M, et al. (2005) Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol 62, 738-741. (Pubitemid 40825945)
48. 3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol 65, 593-597.
49. 3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 27, 181-188.
50. Chiu KC, Chu A, Go VL, et al. (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 79, 820-825. (Pubitemid 41103882)
51. Boucher BJ, Mannan N, Noonan K, et al. (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38, 1239-1245.
52. McCarty MF & Thomas CA (2003) PTH excess may promote weight gain by impeding catecholamine-induced lipolysis - implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 61, 535-542.
53. Bolland MJ, Grey AB, Gamble GD, et al. (2005) Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrin Metab 90, 1525-1530.
54. Bell NH, Epstein S, Greene A, et al. (1985) Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76, 370-373. (Pubitemid 15243466)
55. Atkinson RL, Dahms WT, Bray GA, et al. (1978) Parathyroid hormone levels in obesity: effects of intestinal bypass surgery. Miner Electrolyte Metab 1, 315-320. (Pubitemid 9056882)
56. Pittas AG, Harris SS, Stark PC, et al. (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30, 980-986.
57. de Boer IH, Tinker LF, Connelly S, et al. (2008) Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 31, 701-707.
58. 3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57, 258-261.
59. 3. Nephron 68, 41-47.
60. 3 corrects insulin and lipid abnormalities in uremia. Kidney Int 53, 1353-1357.
61. Orwoll E, Riddle M & Prince M (1994) Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 59, 1083-1087. (Pubitemid 24983489)
62. Raghuramulu N, Raghunath M, Chandra S, et al. (1992) Vitamin D improves oral glucose tolerance and insulin secretion in human diabetes. J Clin Biochem Nutr 13, 45-51.
63. Ayesha I, Raghunath M, Sesikeran B, et al. (1998) Effect of oral administration of vitamin D on glucose tolerance and insulin secretion in type 2 diabetes mellitus. Diabetes Nutr Metab 11, 261-265. (Pubitemid 29192197)
64. Szathmary EJ (1987) The effect of Gc genotype on fasting insulin level in Dogrib Indians. Hum Genet 75, 368-372.
65. Iyengar S, Hamman RF, Marshall JA, et al. (1989) On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study. Genet Epidemiol 6, 691-698.
66. Baier LJ, Dobberfuhl AM, Pratley RE, et al. (1998) Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians. J Clin Endocrinol Metab 83, 2993-2996.
67. Hirai M, Suzuki S, Hinokio Y, et al. (1998) Group specific component protein genotype is associated with NIDDM in Japan. Diabetologia 41, 742-743. (Pubitemid 28261415)
68. Hirai M, Suzuki S, Hinokio Y, Hirai A, et al. (2000) Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance. J Clin Endocrinol Metab 85, 1951-1953. (Pubitemid 32269304)
69. Ye WZ, Dubois-Laforgue D, Bellanne-Chantelot C, et al. (2001) Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians. Metabolism 50, 366-369. (Pubitemid 32248987)
70. Klupa T, Malecki M, Hanna L, et al. (1999) Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin. Eur J Endocrinol 141, 490-493.
71. Oh JY & Barrett-Connor E (2002) Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 51, 356-359.
72. Malecki MT, Frey J, Moczulski D, et al. (2003) Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes 111, 505-509. (Pubitemid 38101497)
73. Ortlepp JR, Metrikat J, Albrecht M, et al. (2003) The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 20, 451-454. (Pubitemid 36776004)
74. Ye WZ, Reis AF, Dubois-Laforgue D, et al. (2001) Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol 145, 181-186. (Pubitemid 32707604)
75. Malecki MT, Klupa T, Wolkow P, et al. (2003) Association study of the vitamin D: 1a-hydroxylase (CYP1a) gene and type 2 diabetes mellitus in a Polish population. Diabetes Metab 29, 119-124. (Pubitemid 36576089)
76. Smogorzewski M, Zayed M, Zhang YB, et al. (1993) Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am J Physiol 264, H1998-H2006. (Pubitemid 23205973)
77. Ni Z, Smogorzewski M & Massry SG (1994) Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology 135, 1837-1844. (Pubitemid 24363874)
78. Christakos S, Dhawan P, Liu Y, et al. (2003) New insights into the mechanisms of vitamin D action. J Cell Biochem 88, 695-705. (Pubitemid 36258819)
79. Zehnder D, Bland R, Williams MC, et al. (2001) Extrarenal expression of 25-hydroxyvitamin D(3)-1α-hydroxylase. J Clin Endocrinol Metab 86, 888-894.
80. Flanagan JN, Wang L, Tangpricha V, et al. (2003) Regulation of the 25-hydroxyvitamin D-1α-hydroxylase gene and its splice variant. Recent results. Cancer Res 164, 157-167.
81. Li J, Byrne ME, Chang E, et al. (2008) 1α-25- Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem 112, 122-126.
82. Ishida H, Suzuki K, Someya Y, et al. (1993) Possible compensatory role of parathyroid hormone-related peptide on maintenance of calcium homeostasis in patients with non-insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh) 129, 519-524. (Pubitemid 2031555)
83. Kadowaki S & Norman AW (1984) Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 73, 759-766. (Pubitemid 14156858)
84. 3. J Endocrinol 148, 223-232.
85. 3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 160, 87-95.
86. 3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats. J Endocrinol Invest 18, 673-682.
87. 3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat. Br J Pharmacol 121, 751-758.
88. 3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89-90, 121-125.
89. 3 and vitamin E on insulin-induced glucose uptake in rat adipocytes. Diabetes Res Clin Pract 55, 175-183.
90. Maestro B, Davila N, Carranza MC, et al. (2003) Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84, 223-230. (Pubitemid 36514839)
91. 3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47, 383-391.
92. Pepe J, Romagnoli E, Nofroni I, et al. (2005) Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int 16, 805-812. (Pubitemid 40933597)
93. Teegarden D, Legowski P, Gunther CW, et al. (2005) Dietary calcium intake protects women consuming oral contraceptives from spine and hip bone loss. J Clin Endocrinol Metab 90, 5127-5133. (Pubitemid 41262264)
94. Kumar S, Olukoga AO, Gordon C, et al. (1994) Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 40, 47-53. (Pubitemid 24193126)
95. Malecki MT, Klupa T, Wanic K, et al. (2002) Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population. Diabetes Res Clin Pract 57, 99-104. (Pubitemid 34626448)
96. Taylor WH & Khaleeli AA (2001) Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 17, 175-180. (Pubitemid 32624600)
97. Chiu KC, Chuang LM, Lee NP, et al. (2000) Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 49, 1501-1505.
98. Thomas DM, Rogers SD, Sleeman MW, et al. (1995) Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line. J Mol Endocrinol 14, 263-275.
99. Reusch JE, Begum N, Sussman KE, et al. (1991) Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology 129, 3269-3273.
100. Perna AF, Fadda GZ, Zhou XJ, et al. (1990) Mechanisms of impaired insulin secretion after chronic excess of parathyroid hormone. Am J Physiol 259, F210-F216. (Pubitemid 20257478)
101. Chang E, Donkin S & Teegarden D (2007) Parathyroid hormone modulates insulin-stimulated glucose uptake in differentiated adipocytes. FASEB J 21, A1111.
102. 3 targeting of NF-kB suppresses high glucoseinduced MCP-1 expression in mesangial cells. Kidney Int 72, 193-201.
103. Sun J, Kong J, Duan Y, et al. (2006) Increased NF-κB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 291, E315-E322. (Pubitemid 44035291)
104. Adams LS & Teegarden D (2004) 1,25-Dihydroxychole-calciferol inhibits apoptosis in C3H10T1/2 murine fibroblast cells through activation of nuclear factor κB. J Nutr 134, 2948-2952.
105. Cohen-Lahav M, Shany S, Tobvin D, et al. (2006) Vitamin D decreases NFκB activity by increasing IκBα levels. Nephrol Dial Transplant 21, 889-897.
106. 3 in macrophages. J Steroid Biochem Mol Biol 103, 558-562.
107. Giulietti A, van Etten E, Overbergh L, et al. (2007) Monocytes from type 2 diabetic patients have a proinflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 77, 47-57.
108. Krishnan AV, Moreno J, Nonn L, et al. (2007) Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity. J Bone Miner Res 22, Suppl. 2, V74-V80. (Pubitemid 351304654)
109. Miele C, Riboulet A, Maitan MA, et al. (2003) Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C a-mediated mechanism. J Biol Chem 278, 47376-47387. (Pubitemid 37523177)
110. Talmor Y, Golan E, Benchetrit S, et al. (2008) Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 294, F1059-F1064.